Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis.

Yilmaz, M

Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis. [electronic resource] - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Jul 2012 - 2059-62 p. digital

Publication Type: Case Reports; Journal Article

1433-2965

10.1007/s00198-011-1836-2 doi


Adult
Alendronate--adverse effects
Bone Density Conservation Agents--adverse effects
Humans
Male
Nephrotic Syndrome--chemically induced
Osteoporosis--drug therapy